After experiencing significant growth in the clinical trial solutions market in 2021, Crucial Data Solutions has added another industry veteran to its leadership team.
Reno, NV, June 27, 2022 — Crucial Data Solutions (CDS), a provider of innovative low-code/no-code technologies to advance clinical research, announced today that industry veteran Brian Dufrense has joined the company as Senior Vice President, Business Development. In his role, Brian will be responsible for building out the commercial team to support the company’s continued growth. This new appointment is a reflection of CDS’ record 73% year-over-year profitable revenue growth from 2017 through 2021.
CDS’ low-code/no-code data collection and study management platform, TrialKit, continues to capture market share by delivering the most comprehensive, end-to-end technology to support clinical trials.
Brian Dufresne, B.S., brings over 25 years of sales and leadership experience, the majority of which have been in start-up and emerging growth technology companies. As an expert in both technology and clinical research, Brian previously worked at Phase Forward, Greenphire and Appian. He has spent his whole career in life sciences and has a passion for getting essential medications and treatments to patients faster by helping life sciences companies leverage innovative, scalable technologies to reduce time, cost, and risk.
“I joined CDS because their world-class clinical technology is an affordable alternative to much more expensive and complex options and allows smaller organizations to have greater access to state-of-the-art technology to run their clinical trials without compromise,” Dufrense said.
“We’re excited that an industry veteran with Brian’s depth and breadth of experience in eClinical systems has agreed to join the CDS team. His customer relationship and leadership skills will allow us to continue to scale our business while maintaining the level of attention and responsiveness that have become synonymous with the Crucial Data Solutions brand,” said Jeff Rogers, President of CDS. “We’re looking forward to his contributions that will allow us to further support the growing demand for TrialKit over the past five years.”
About Crucial Data Solutions
Founded in 2010, Crucial Data Solutions (CDS) provides the most innovative low-code/no-code data and clinical trial management technology on the market today. TrialKit, our cloud-based platform available via both a web and native mobile app, enables end-to-end clinical trial management for medical device, diagnostics, digital therapeutics, and biotechnology companies of all sizes. Design and deploy validated studies in days not weeks using our intuitive study builder that requires no programming. Over 10,000 global users have leveraged the flexibility of TrialKit to deploy over 7,000 studies across all phases of development, including Verily (a subsidiary of Alphabet), ICON GPHS, FUEL Studios, Catalyst Clinical Research, SISCAPA Assay Technologies, CDx Diagnostics, and Optinose, and many more. Learn more at https://crucialdatasolutions.com/
Director of Marketing
Crucial Data Solutions